Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt

Original announcement by tmx on

Company
Voyageur Pharmaceuticals Ltd.
Ticker
VM
Exchange
TSX
Region
British Columbia
Primary commodity
Barium
Secondary commodities
Iodine
Document categories
Metallurgy, Other
Extracted
2026-08-21 01:27:37 UTC

Analysis by Minestarters Atlas

Minestarters Atlas analysis

Summary

Voyageur Pharmaceuticals has confirmed that its Frances Creek barite meets pharmaceutical-grade purity standards, with an average BaSO4 assay of 98.8%. The company is progressing toward Health Canada human trials and has secured non-dilutive funding through the Alberta Innovates program.

Reasoning: The company confirmed pharmaceutical-grade purity for its barite API, a major technical milestone for its vertically integrated business model.

Positive factors

  • High purity results (98.8% average) exceeding USP standards
  • Successful micronization to ultra-fine particle sizes
  • De-risking milestone for pharmaceutical-grade API
  • Non-dilutive funding support from Alberta Innovates

Negative factors

  • Upcoming clinical trials represent significant regulatory risk

Facts used in scoring: 2

Atlas analysis — Voyageur Pharmaceuticals Ltd.: Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt. 100% recovery

Classification and evidence

Free Millingpositive

Simple, clean ore amenable to standard processing without oxidation.

Why it applies: The material processes efficiently into ultra-fine particles with high yield and purity.

Evidence · text

“demonstrated that the material processes efficiently into ultra-fine particles”

QA/QC Disclosedpositive · Story-specific tag

Release includes QA/QC disclosure — certified lab, QP sign-off, or stated methods (blanks, standards, duplicates).

Why it applies: Testing was completed by SGS Laboratories and met USP monograph requirements.

Evidence · text

“Testing by SGS Laboratories... confirmed purity, with % BaSO4 assay results ranging from 98.1% to 99.4%”

Extracted facts

Stored fact records: 2. Some facts used in scoring do not have a stored record.

Metallurgical Results (2)

assaybariumHead Grade: 98.8Head Grade Unit: %View all details
Link to this fact

Identity

Commodity
barium
Ticker
VM

Test Work

Program Status
detailed
Test Type
assay
Processing Route
controlled acid-wash procedure
Sample
Frances Creek barium sulfate API samples

Recovery

Head Grade
98.8
Head Grade Unit
%

Lab

Laboratory
SGS Laboratories

Review

Needs Review
No
Historical
No

Dates

Event date
2026-03-04T00:00:00.000Z

Reasoning: Average purity of 98.8% BaSO4 is exceptionally high and meets pharmaceutical standards.

Positive factors

  • Purity exceeds USP monograph requirement of 97.5%

Evidence · text

“average grade of 98.8%”
micronizationbariumRecovery: 100 %View all details
Link to this fact

Identity

Commodity
barium
Ticker
VM

Test Work

Test Type
micronization
Sample
micronized barite

Recovery

Recovery
100 %

Review

Needs Review
No
Historical
No

Dates

Event date
2026-03-04T00:00:00.000Z

Reasoning: Successful processing into ultra-fine particles with 100% yield.

Positive factors

  • 100% yield achieved during micronization

Evidence · text

“exhibited good flowability, 100% yield”

How Atlas produces this analysis

Minestarters Atlas uses automated extraction to summarize mining announcements, identify reported measurements, and classify supporting evidence. Sentiment reflects the extracted narrative and classification rules; it is an interpretation, not a reported measurement. Evidence quotes and context are provided where available. Missing data, low-confidence results, and review flags indicate limitations. Check the original publisher announcement before relying on an interpretation.